Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma Forty-three percent of patients achieved ...

Clin Lymphoma Myeloma. 2010;10(4):278-280. Our study has several limitations. Clinical information on the patients studied was incomplete, in part because half of the serum specimens came from ...

A 41-year-old male with IgG kappa multiple myeloma is described. He developed a free gamma heavy chain without an accompanying light chain following high-dose chemotherapy and autologous peripheral ...

AUGUSTA, Ga. (July 13, 2018) -When it comes to diagnosing a condition in which the plasma cells that normally make antibodies to protect us instead become cancerous, it may be better to look at the ...

Serum free light-chain (FLC) concentrations were measured by a sensitive nephelometric immunoassay in 66 patients with AL amyloidosis before and after treatment with high-dose melphalan and autologous ...

Along with these studies, the NCCN also recommends additional serum and urine analyses. The serum is analyzed to determine immunoglobulin levels, how much monoclonal protein is present (through serum ...

Researchers highlighted the opportunities primary care providers (PCPs) have to promote favorable outcomes through prompt diagnosis as well as help reduce racial disparities in multiple myeloma.

A series of tests physicians routinely order to help diagnose and follow their patients with an elevated antibody level that is a marker for cancer risk, often do not benefit the patient but do ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A 43-year-old female presented to the ...

Please provide your email address to receive an email when new articles are posted on . Utilization of pyrophosphate imaging to identify patients with cardiac amyloidosis has increased, although ...

Background: Diagnosis of monoclonal gammopathies (MGs) is determined by demonstration of a monoclonal immunoglobulin molecule or chain in serum and/or urine. Previous results on immunofixation ...